Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Chemistry Outsourcing

Chemistry Outsourcing

Date: Tuesday, 13 March 2012 - Wednesday, 14 March 2012
Location: Munich, Germany


Keynote Speakers

Richard Soll

Richard Soll
Senior Vice President, WuxiAppTec

Thierry Langer

Thierry Langer
CEO, Prestwick Chemical

Overview

Welcome to the Chemistry Outsourcing track of the Discovery Chemistry Congress and exhibition. This year's event will be held in Munich, Germany.

Global competitiveness is becoming increasingly important for the pharmaceutical industry. This financial pressure is forcing companies to constantly explore options to enhance the efficiency of all stages of their drug discovery pipeline, particularly at the discovery chemistry phase.

Chemistry outsourcing, in particular, can offer a number of benefits, namely reducing costs, increasing flexibility and expanding a company knowledge base. However, effective outsourcing does not come without problems, such as patent issues, poor partner relationships and project complexity. It requires the correct selection of an outsourcing partner as well as sound management to effectively integrate external knowledge bases with internal ones.

Select Biosciences’ Chemistry Outsourcing conference will bring together decision makers from both pharmaceutical companies and CRO’s to provide advice on, and to discuss these issues. Focus will also be given to the opportunities that emerging outsourcing destinations can provide, along with future trends for outsourcing.

Delegates will also have access to the other three co-located Discovery Chemistry Congress tracks; Fragment-Based Lead Discovery, Structural & Computational Chemistry and Formulation & Solubility, ensuring a highly informative and value for money event.

Agenda Topics

  • Emerging Outsourcing Destinations
  • Finding the Right Partner
  • IP Issues
  • Managing the Partnership
  • New Trends in Outsourcing
  • Open Innovation
  • Risks and Benefits of Outsourcing
  • Selecting the Best Outsourcing Strategy

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

, ,
Michael Barnes, Co Founder, OI Pharma Partners Ltd
Jorge Beleta, Director, Almirall R&D
Gunter Festel, Co Founder, Autodisplay Biotech
Stephan Jenn, President, Novalix
Duncan Judd, Consultant, Awridian
Hansjoerg Lehmann, Lab Head, Novartis Pharmaceuticals UK Limited
Andy McElroy, CEO, The Research Network Ltd
Richard Morphy, Senior Research Advisor, Eli Lily/Schering Plough Corporation
Arthur Oubrie, Chief Scientific Officer, Lead Pharma
Thomas Rudolph, Partner, McKinsey & Company
Thomas Saunders, Of Counsel, Rissman Hendricks & Oliverio
Sunil Shah, Director, Piramal Discovery Solutions (Formerly O2h)
Hiroshi Sheraton, Partner, McDermott Will & Emery
Stephen Shuttleworth, CSO, Karus Therapeutics
Alain Vertes, Director, Bio Duro
Claire Willsher, Outsourcing Manager, Lundbeck
Jim Zhang, President, JZMed


Corporate Sponsors Media Sponsors Networking
U-Networks

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonChemistry OutsourcingSELECTBIOenquiries@selectbiosciences.com